Enanta Pharmaceuticals Inc
ENTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001177648
No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Enanta Pharmaceuticals Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 152 | 1 | 149 | −2 |
| Shares | 18.8M | 10.5K | 19.4M | +583.5K (+3.1%) |
| Value | $828.7M | $463.0K | $1.10B | +$274.2M (+33.1%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Soleus Capital Management, L.P. | 182,400 | $10.4M | 1.61% |
| Portland Global Advisors LLC | 62,635 | $3.56M | 0.66% |
| TD Asset Management Inc | 19,000 | $1.08M | 0.00% |
| Voloridge Investment Management, LLC | 12,164 | $691.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 11,413 | $648.0K | 0.01% |
| Guggenheim Capital LLC | 7,692 | $437.0K | 0.00% |
| Maryland State Retirement & Pension System | 7,079 | $399.0K | 0.01% |
| CWM Advisors, LLC | 4,158 | $236.0K | 0.03% |
| Lazard Asset Management LLC | 1,145 | $65.0K | 0.00% |
| Fifth Third Bancorp | 19 | $1.00K | 0.00% |
| Glassman Wealth Services | 5 | $0 | 0.00% |
| Meridian Wealth Partners, LLC | 3 | $0 | 0.00% |
Sold out (14)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| AXA S.A. | 62,400 | $2.75M |
| Exchange Traded Concepts, LLC | 20,169 | $888.0K |
| Jane Street Group, LLC | 9,060 | $399.0K |
| First Quadrant L P | 9,013 | $397.0K |
| Jump Financial, LLC | 8,400 | $370.0K |
| Trexquant Investment LP | 7,958 | $350.0K |
| 6 Meridian | 7,390 | $325.0K |
| Aigen Investment Management, LP | 6,987 | $307.0K |
| Fisher Asset Management, LLC | 6,601 | $291.0K |
| Gsa Capital Partners LLP | 6,281 | $276.0K |
| Royce & Associates LP | 5,340 | $235.0K |
| Squarepoint Ops LLC | 4,924 | $217.0K |
| Everence Capital Management Inc | 4,780 | $210.0K |
| Group One Trading, L.P. | 6 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 10,500 | $463.0K |